KeithKayeMD
Infectious Disease • Ann Arbor, MIProfessor, Internal Medicine, Wayne State University SOM
Dr. Kaye is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1500 East Medical Center Drive
Ann Arbor, MI 48109Phone+1 313-745-7105Fax+1 313-993-0302- Is this information wrong?
Education & Training
Beth Israel Deaconess Medical CenterFellowship, Infectious Disease, 1997 - 2000- Beth Israel Deaconess Medical CenterResidency, Internal Medicine, 1994 - 1997
Perelman School of Medicine at the University of PennsylvaniaClass of 1994
Certifications & Licensure
NJ State Medical License 2021 - 2025
MI State Medical License 2008 - 2024
NC State Medical License 2000 - 2009- American Board of Internal Medicine Infectious Disease
Clinical Trials
- Trial for the Treatment of Extensively Drug-Resistant Gram-negative Bacilli (OVERCOME) Start of enrollment: 2012 Oct 06
- Optimizing Clinical Use of Polymyxin B Start of enrollment: 2016 Feb 01
- Pulsed UV Xenon Disinfection to Prevent Resistant Healthcare Associated Infection Start of enrollment: 2017 Jul 07
Publications & Presentations
PubMed
- Unitary Tract Infection Treatment: When to Use What Agents including Beta-lactam Combination Agents.Arsheena Yassin, Keith S Kaye, Tanaya Bhowmick> ;Infectious Disease Clinics of North America. 2024 Apr 8
- Evidence of transmission of New Delhi metallo-β-lactamase-producingthrough a gastrointestinal endoscope without an elevator channel.Ann Fan Yang, Adrienne Sherman, Elizabeth Nazarian, Wolfgang Haas, Jason Mehr, Michele Pedrani, Thomas Kirn, Steven Brant, Susan E Boruchoff, Keith S Kaye, John P Mills> ;Infection Control and Hospital Epidemiology. 2024 Apr 2
- Sulbactam-durlobactam: a β-lactam/β-lactamase inhibitor combination targeting.Mills, J. P., Sarah M McLeod, John P O'Donnell, Navaneeth Narayanan, John P Mills, Keith S Kaye> ;Future Microbiology. 2024 Mar 1
- Join now to see all
Journal Articles
- Epidemiology of Diabetic Foot Infection in the Metro-Detroit Area with a Focus on Independent Predictors for Pathogens Resistant to Recommended Empiric Antimicrobial T...Keith S Kaye, Paul E Kilgore, Kathryn Deeds, Rahul Pansare, Bushra Joarder, Sorabh Dhar, Open Forum Infectious Diseases
- Ceftazidime/avibactam, Meropenem/vaborbactam or Both? Clinical and Formulary ConsiderationsRobert A Bonomo, Keith S Kaye, Clinical Infectious Diseases
Lectures
- Internal Medicine Update: Inpatient & Outpatient Care for the Hospitalist & PCPAmerican Medical Seminars, Inc., Sarasota, Florida - 11/21/2011
- A Systematic Review and Meta-analysis of the Association between Hyperglycemia and Surgical Site InfectionsDetroit, MI - 6/15/2014
Other
- Infections and antimicrobial resistance in the intensive care unitKaye K, Marchaim D
http://www.uptodate.com/contents/infections-and-antimicrobial-resistance-in-the-intensive-care-unit
UpToDate, Wolters Kluwer Health - 2012-10-03
Press Mentions
Results from Pivotal Phase 3 ATTACK Trial of Investigational Sulbactam-Durlobactam for Treatment of Serious Infections Caused by Acinetobacter Published in the Lancet Infectious DiseasesMay 11th, 2023- FAQs: Improving Empiric Antibiotic Regimens for HABP/VABP in the ICUDecember 6th, 2022
- A New, More Effective UTI DrugNovember 23rd, 2022
- Join now to see all
Hospital Affiliations
DMC Harper University HospitalDetroit, Michigan
University of Michigan Medical CenterAnn Arbor, Michigan
Robert Wood Johnson University HospitalNew Brunswick, New Jersey
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
